Literature DB >> 2340323

Effects of age and gender on CNS serotonergic responsivity in normal adults.

P A McBride1, H Tierney, M DeMeo, J S Chen, J J Mann.   

Abstract

The effects of age and gender on central nervous system (CNS) serotonergic responsivity were assessed with a neuroendocrine challenge test in 30 normal adults. Subjects greater than or equal to 30 years of age, compared with younger subjects, exhibited decreased prolactin secretion in response to a 60-mg oral dose of dl-fenfluramine hydrochloride, an indirect serotonin agonist. Furthermore, women had greater prolactin responses than men. As prolactin secretory capacity appears to be stable through midlife, the age-associated decrease in fenfluramine-induced prolactin release suggests a decline in CNS serotonergic responsivity. In contrast, the finding of greater prolactin release in women than in men probably reflects the effects of nonserotonergic modulatory influences at the level of the lactotroph. Age and gender effects must be considered in studies of the CNS serotonergic system.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2340323     DOI: 10.1016/0006-3223(90)90051-3

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  13 in total

1.  Influence of age on the GH response to sumatriptan administration in man.

Authors:  V Coiro; R Volpi; C Davoli; G Caffarri; P Chiodera
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  Gender, personality, and serotonin-2A receptor binding in healthy subjects.

Authors:  Paul H Soloff; Julie C Price; Neale Scott Mason; Carl Becker; Carolyn C Meltzer
Journal:  Psychiatry Res       Date:  2010-01-30       Impact factor: 3.222

3.  Platelet monoamine oxidase B (MAO-B) activity and its relationship to DL-fenfluramine-induced prolactin response in healthy men.

Authors:  M Eriksson; U Berggren; C Fahlke; J Engel; J Balldin
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

Review 4.  Effects of dietary polyunsaturated fatty acids on neuronal function.

Authors:  J D Fernstrom
Journal:  Lipids       Date:  1999-02       Impact factor: 1.880

5.  Association between somatization subscale score and serotonin transporter availability in healthy volunteers--a single photon emission computed tomography study with [¹²³I] ADAM.

Authors:  Ming Hui Chou; Kao Chin Chen; Tzung Lieh Yeh; I Hui Lee; Wei Jen Yao; Po See Chen; Kang-Wei Chang; Mei-Hsiu Liao; Yen Kuang Yang
Journal:  Psychopharmacology (Berl)       Date:  2011-08-16       Impact factor: 4.530

6.  Clomipramine-induced serum prolactin as a marker for serotonin and dopamine turnover: results of an open label study.

Authors:  Joachim Cordes; Kai G Kahl; Christian Werner; Uwe Henning; Gunnar Regenbrecht; Rolf Larisch; Christian Schmidt-Kraepelin; Johanna Thünker; Marcus W Agelink; Stefan Löffler; Thomas Hohlfeld; Wolfgang Gaebel; Ansgar Klimke
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-03-15       Impact factor: 5.270

Review 7.  Why are women diagnosed borderline more than men?

Authors:  Andrew E Skodol; Donna S Bender
Journal:  Psychiatr Q       Date:  2003

8.  The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635.

Authors:  Patrycja Stein; Markus Savli; Wolfgang Wadsak; Markus Mitterhauser; Martin Fink; Christoph Spindelegger; Leonhard-Key Mien; Ulrike Moser; Robert Dudczak; Kurt Kletter; Siegfried Kasper; Rupert Lanzenberger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-06-10       Impact factor: 9.236

9.  A comparison of d, l-fenfluramine and citalopram challenges in healthy adults.

Authors:  Janine D Flory; Stephen B Manuck; James M Perel; Matthew F Muldoon
Journal:  Psychopharmacology (Berl)       Date:  2004-03-02       Impact factor: 4.530

Review 10.  Antibodies as molecular probes in neurobiology. Identification of chemically defined neurons and synapses in tissues and tissue cultures.

Authors:  J Pecci Saavedra; A Brusco; J J López-Costa; L A Gómez; E M López
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.